Search Results - "Verburgh ML"

Understanding of HIV cure research in a rural community with high prevalence: the case of uMkhanyakude district, KwaZulu-Natal, South Africa.

Authors: Chimukuche, Rujeko Samanthia Magongo, Miliswa Shandu, Qinisile et al.

Source: AIDS Research & Therapy; 10/17/2025, Vol. 22 Issue 1, p1-8, 8p

Subject Terms: HIV infection epidemiology, HIV prevention, COMMUNITY health services, RESEARCH funding, QUALITATIVE research, LEADERSHIP, SOCIOECONOMIC factors, PUBLIC opinion, DESCRIPTIVE statistics, JUDGMENT sampling, COMMUNITIES, THEMATIC analysis, SOUND recordings, MEDICAL research, RURAL population, CONCEPTUAL structures

Geographic Terms: SOUTH Africa

Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4⁺ T-cell count in the Netherlands: A two-year follow-up study.

Authors: Jongkees, Marlou J. Bogers, Susanne de Vries, Rory D. et al.

Source: PLoS ONE; 5/19/2025, Vol. 20 Issue 5, p1-13, 13p

Subject Terms: BOOSTER vaccines, VACCINE immunogenicity, HIV infections, BREAKTHROUGH infections, COVID-19 vaccines

Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study.

Authors: Abela, Irene A Hauser, Anthony Schwarzmüller, Magdalena et al.

Source: Journal of Infectious Diseases; 8/15/2024, Vol. 230 Issue 2, pe292-e304, 13p

Subject Terms: SARS-CoV-2, HIV, CORONAVIRUSES, POLYMERASE chain reaction, ANTIBODY formation

Author Index.

Source: HIV Medicine; Oct2021 Supplement S1, Vol. 22, p310-327, 18p

Cross-sectional analysis of factors associated with low intrinsic capacity among Malaysians ageing with HIV in ambulatory care.

Authors: Yap, Siew Hwei Hisham, Syaza Ho, Wen Ying et al.

Source: AIDS (02699370); 9/1/2025, Vol. 39 Issue 11, p1524-1535, 12p

"I don't see a reason why we should be hidden from view": Views of a convenience sample of people living with HIV on sharing HIV status data in routinely collected health and care databases in England.

Authors: Ford, Elizabeth Goddard, Katie Smith, Michael et al.

Source: PLoS ONE; 2/12/2025, Vol. 20 Issue 2, p1-27, 27p

Subject Terms: CONVENIENCE sampling (Statistics), HIV-positive persons, TRUST, HIV status, INFORMATION sharing

Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation.

Authors: Karim, Farina Riou, Catherine Bernstein, Mallory et al.

Source: Nature Communications; 3/15/2024, Vol. 15 Issue 1, p1-16, 16p

Untreated HIV-1 infection and low CD4⁺ T cell counts and their effect on endemic human coronavirus (re)infection.

Authors: Sechan, Ferdyansyah van den Hurk, Anne W. M. Boender, T. Sonia et al.

Source: PLoS Global Public Health; 6/18/2025, Vol. 5 Issue 6, p1-12, 12p

Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIV.

Authors: Damas, José Munting, Aline Fellay, Jacques et al.

Source: Clinical Infectious Diseases; 10/15/2024, Vol. 79 Issue 4, p990-998, 9p

Subject Terms: LAMIVUDINE, RILPIVIRINE, ANTIRETROVIRAL agents, AFRICAN Americans, RESEARCH funding, BODY weight, DRUG therapy, TENOFOVIR, HIV-positive persons, LIPIDS, HIV infections, DESCRIPTIVE statistics, LONGITUDINAL method, CHOLESTEROL, WAIST-hip ratio, ANTHROPOMETRY, CONFIDENCE intervals, TRIGLYCERIDES, TIME

Geographic Terms: SWITZERLAND

CIAE: a consistency- and informativeness-aware explanation framework for improving type 2 diabetes prediction and mechanistic insights.

Authors: Wang, Ning Gu, Wenchao Liu, Shuoming et al.

Source: PeerJ Computer Science; Oct2025, p1-27, 27p

Subject Terms: TYPE 2 diabetes, GLYCEMIC control, ARTIFICIAL intelligence, GUT microbiota, MACHINE learning

Low-Level Viremia as an Independent Risk Factor for Metabolic Syndrome in People Living with HIV Receiving Antiretroviral Therapy: A 6-Year Retrospective Cohort Study.

Authors: Wang, Zixuan Jin, Yong Qian, Guoqing

Source: Infection & Drug Resistance; Oct2025, Vol. 18, p5627-5642, 16p

Gut microbiota: a promising new target in immune tolerance.

Authors: Almansour, Nourah Al-Rashed, Fatema Choudhry, Khubaib et al.

Source: Frontiers in Immunology; 2025, p1-24, 24p

Subject Terms: GUT microbiota, IMMUNOLOGICAL tolerance, DRUG target, DYSBIOSIS, IMMUNE response, AUTOIMMUNE diseases, MICROBIAL metabolites, MICROBIAL diversity

Interleukin‐2‐mediated CD4 T‐cell activation correlates highly with effective serological and T‐cell responses to SARS‐CoV‐2 vaccination in people living with HIV.

Authors: Gupta, Akshita Righi, Elda Konnova, Angelina et al.

Source: Journal of Medical Virology; Aug2024, Vol. 96 Issue 8, p1-14, 14p

Subject Terms: SARS-CoV-2, ANTIBODY titer, HIV-positive persons, IMMUNOGLOBULIN G, AIDS vaccines

Regional variation in weight change after the transition to dolutegravir in Uganda and South Africa.

Authors: Migisha, Richard Chen, Geoffrey Muyindike, Winnie R. et al.

Source: AIDS (02699370); Jul2024, Vol. 38 Issue 9, p1314-1322, 9p

Distinct metabolic perturbations link liver steatosis and incident CVD in lean but not obese PWH.

Authors: van Eekeren, Louise E. Vadaq, Nadira Blaauw, Marc J. T. et al.

Source: BMC Medicine; 2/11/2025, Vol. 23 Issue 1, p1-17, 17p

Subject Terms: NUCLEAR magnetic resonance spectroscopy, AMINO acid metabolism, DISEASE risk factors, PERIPHERAL vascular diseases, HEPATIC fibrosis

Assessing intrinsic capacity for person‐centred HIV care: a cross‐sectional study in ageing populations in Malaysia and Hong Kong.

Authors: Rajasuriar, Reena Hisham, Syaza Lim, John Son et al.

Source: Journal of the International AIDS Society; Jan2025, Vol. 28 Issue 1, p1-12, 12p

Subject Terms: ACTIVITIES of daily living, MEDICAL centers, COGNITION, ANTIRETROVIRAL agents, HIV-positive persons

Geographic Terms: PACIFIC Area

Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis.

Authors: Berenguer, Juan Aldámiz-Echevarría, Teresa Hontañón, Víctor et al.

Source: Hepatology (02709139); Jan2025, Vol. 81 Issue 1, p238-253, 16p

Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection.

Authors: Peluso, Michael J. Spinelli, Matthew A. Deveau, Tyler-Marie et al.

Source: AIDS (02699370); Oct2022, Vol. 36 Issue 12, pF7-F16, 10p

Factors associated with oxidative stress in virologically suppressed people living with HIV on long-term antiretroviral therapy.

Authors: Lombardi, Francesca Belmonti, Simone Sanfilippo, Alessia et al.

Source: AIDS Research & Therapy; 12/30/2024, Vol. 21 Issue 1, p1-11, 11p

Subject Terms: THERAPEUTIC use of antioxidants, RNA analysis, ANTIOXIDANT analysis, RISK assessment, CROSS-sectional method, REFERENCE values, HIGH density lipoproteins, COMBINATION drug therapy, ANTIRETROVIRAL agents, VIRAL load, RESEARCH funding, HIV-positive persons, SEX distribution, HIV infections, OXIDATIVE stress, METABOLITES, OXIDIZING agents, PROTEASE inhibitors, CONFIDENCE intervals, HEPATITIS C, REGRESSION analysis, MIXED infections

Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections.

Authors: Alirezaylavasani, Amin Skeie, Linda Gail Egner, Ingrid Marie et al.

Source: NPJ Vaccines; 10/9/2024, Vol. 9 Issue 1, p1-15, 15p

Subject Terms: VACCINE effectiveness, CELLULAR immunity, BREAKTHROUGH infections, HIV-positive persons, CD4 lymphocyte count